Myositis ossificans progressiva, unspecified toe(s)
ICD-10 M61.179 is a billable code used to indicate a diagnosis of myositis ossificans progressiva, unspecified toe(s).
Myositis ossificans progressiva (MOP) is a rare genetic disorder characterized by the abnormal formation of bone in muscles and connective tissues. This condition typically begins in early childhood and progresses over time, leading to significant muscle weakness and restricted mobility. In the case of unspecified toe(s), the ossification may occur in the muscles surrounding the toes, resulting in stiffness and pain. Patients may experience episodes of inflammation and swelling in the affected areas, which can further complicate mobility. The condition is caused by mutations in the ACVR1 gene, which plays a crucial role in bone and muscle development. Diagnosis is often confirmed through clinical evaluation, imaging studies, and genetic testing. Management focuses on symptomatic relief, physical therapy, and avoiding activities that may exacerbate the condition. Due to the progressive nature of MOP, early intervention is critical to maintaining function and quality of life.
Detailed clinical notes on symptoms, progression, and treatment plans.
Patients presenting with muscle weakness, pain, and restricted mobility.
Documentation should include genetic testing results and any imaging studies performed.
Genetic testing results and family history of similar conditions.
Patients with a family history of myositis ossificans or unexplained muscle ossification.
Ensure that genetic counseling notes are included in the documentation.
Used for follow-up visits for patients with MOP.
Document history, examination findings, and treatment plan.
Rheumatology and genetics specialties may have specific documentation needs.
Myositis ossificans progressiva is a rare genetic disorder characterized by the abnormal formation of bone in muscles and connective tissues, leading to progressive disability.
